This study is testing a new treatment for ADHD (Attention-Deficit/Hyperactivity Disorder), which is a condition that makes it hard for people to pay attention and control their impulses. The study will last for 6 weeks and involves trying two different medicines, NRCT-101SR and NRCT-202XR, to see if they work better when used together. Participants will be randomly placed into different groups to compare the treatments. The study needs about 60 kids, aged 13-17, who are already taking ADHD medicine.
- The study lasts for 6 weeks with multiple visits.
- Participants might get different doses of medication.
- Parental consent and involvement are necessary.